Ocular Therapeutix
OCUL
OCUL
132 hedge funds and large institutions have $215M invested in Ocular Therapeutix in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
25% less capital invested
Capital invested by funds: $288M → $215M (-$73.2M)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
Holders
132
Holding in Top 10
3
Calls
$771K
Puts
$883K
Top Buyers
| 1 | +$3.45M | |
| 2 | +$2.46M | |
| 3 | +$2.39M | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$1.94M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.3M |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$831K | |
| 3 | -$797K | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$747K |
| 5 |
Man Group
London,
United Kingdom
|
-$746K |